|
FR3100035A1
|
|
USE OF IN VITRO ANNELID HEMOGLOBIN
|
|
FR3080002A1
|
|
PROCESS FOR MONITORING THE VIABILITY OF A GRAFT
|
|
FR3076713A1
|
|
USE OF ANNELID HEMOGLOBIN AS A BACTERICIDE, IN PARTICULAR FOR THE PREVENTION AND / OR TREATMENT OF PERIODONTAL DISEASE
|
|
EP2923707A1
|
|
Blood substitute with respiratory pigment
|
|
FR3005663A1
|
|
VERBAL LYOPHILISATE AND USES THEREOF
|
|
FR3002146A1
|
|
USE OF ANNILIDES HEMOGLOBIN FOR THE TREATMENT OF CANCERS
|
|
FR2991327A1
|
|
HEMOGLOBIN LYOPHILIZATION METHOD OF ANNELIDES
|
|
FR2979352A1
|
|
Use of annilides hemoglobin for maintaining indifferenced stem cells
|
|
FR2975869A1
|
|
ORGAN PRESERVATION COMPOSITION AND USES
|
|
WO2010128159A1
|
|
Novel heamoglobin and uses thereof
|
|
EP2421951A1
|
|
Bioreactor using oxygen-carrying molecules
|
